Dr James Richard Lucas, MD in Davenport, OK - General Practice

Dr James Richard Lucas, MD is a General Practice physician based in Davenport, Oklahoma. Dr James Richard Lucas is licensed to practice in Oklahoma (license number 8941) and his current practice location is 202 Broadway Ave., Davenport, Oklahoma. He can be reached at his office (for appointments etc.) via phone at (918) 377-2237.

NPI number for Dr James Richard Lucas is 1932301900 and his current mailing address is 343800 E 820 Rd, Agra, Oklahoma. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1932301900.

Contact Information

	Dr James Richard Lucas, MD
	202 Broadway Ave., Davenport, OK 74026
	(918) 377-2237
	(918) 377-2239

Physician's Profile

Full Name	Dr James Richard Lucas
Gender	Male
Speciality	General Practice
Location	202 Broadway Ave., Davenport, Oklahoma
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1932301900
Provider Enumeration Date: 06/01/2007
Last Update Date: 06/22/2012

Medical Identifiers

Medical identifiers for Dr James Richard Lucas such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1932301900	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	8941 (Oklahoma)	Primary
208D00000X	General Practice	J3843 (Texas)	Secondary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr James Richard Lucas is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr James Richard Lucas, MD 343800 E 820 Rd, Agra, OK 74824-8419 Ph: (918) 375-2547	Dr James Richard Lucas, MD 202 Broadway Ave., Davenport, OK 74026 Ph: (918) 377-2237

News Archive

Pediatric pain: An interview with Lori Kozlowski

The pain experienced by the infants, children and adolescents in our study was the result of a broad range of medical and surgical conditions.

Tackle Cancer Foundation calls attention to REVLIMID for myeloma patients

The TACKLE CANCER FOUNDATION wants to call attention to important news for patients with the blood cancer multiple myeloma. A new study shows patients benefit from daily medical treatments to keep their cancer in check after they have had a stem cell (bone marrow) transplant. The current standard of care is to give patients the transplant and then hold off on additional treatment until they relapse. The new study shows continuous treatment with the oral drug REVLIMID following the transplant significantly prolongs remission, increasing time to disease progression.

ARIAD Pharmaceuticals presents preclinical data on ponatinib at AACR Annual Meeting 2013

ARIAD Pharmaceuticals, Inc. today announced the presentation of preclinical data on ponatinib (Iclusig) , at the American Association for Cancer Research Annual Meeting 2013, in Washington.

VIVUS second-quarter total revenue decreases to $3.9 million

VIVUS, Inc., a biopharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today reported its financial results for the second quarter and six months ended June 30, 2010.

Novel drug to arrest antibiotic resistance by preventing micro-evolution

Desperate times need desperate measures. Accordingly, scientists, today published a new study in the journal Cell Host and Microbe in March 2020, showing that drugs that prevent the acquisition of DNA-borne antibiotic resistance traits from their surroundings by bacteria can stop mice from becoming resistant to the action of the antibiotics.

Dr James Richard Lucas, MD - General Practice in Davenport, OK